Greater total dose and duration of treatment with bortezomib are associated with higher incidence of chalazion and other ocular side effects Meeting Abstract


Authors: Ganesh, K.; Batlevi, C.; Zhang, Z. G.; Hassoun, H.; Lendvai, N.; Landau, H.; Moskowitz, C. H.; Caron, P.; Motzer, R.; Giralt, S. A.; Hamlin, P.; Lichtman, S. M.; Matasar, M. J.; Portlock, C. S.; Shukla, N.; Wasserheit-Lieblich, C.; Zelenetz, A. D.; Gerecitano, J. F.
Abstract Title: Greater total dose and duration of treatment with bortezomib are associated with higher incidence of chalazion and other ocular side effects
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349242703216
PROVIDER: wos
Notes: Meeting Abstract: 3487 -- Source: Wos
MSK Authors
  1. Zhigang Zhang
    238 Zhang
  2. Carol Portlock
    175 Portlock
  3. Robert Motzer
    716 Motzer
  4. Craig Moskowitz
    367 Moskowitz
  5. Sergio Andres Giralt
    500 Giralt
  6. Stuart Lichtman
    163 Lichtman
  7. Hani Hassoun
    143 Hassoun
  8. Andrew D Zelenetz
    540 Zelenetz
  9. Heather Jolie Landau
    173 Landau
  10. Nikoletta Lendvai
    78 Lendvai
  11. Paul Hamlin
    168 Hamlin
  12. Matthew J Matasar
    116 Matasar
  13. Philip C Caron
    29 Caron
  14. Neerav Shukla
    68 Shukla
  15. Connie Wing-Ching Lee
    39 Lee
  16. Karuna   Ganesh
    8 Ganesh